Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Merck acquired Hawaii Biotech's Dengue fever vaccine program for an undisclosed amount. The program has been evaluated in a Phase I trial. Hawaii Biotech filed for Chapter 11 bankruptcy in December. F...